Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hennig

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2015
Nanoparticles for the treatment of ocular neovascularizationsRobert Hennig, Achim Goepferich
Journal of Pharmaceutical Sciences|August 27, 2019
Determination of the Structural Relaxation Enthalpy Using a Mathematical ApproachKarsten Flügel, Robert Hennig, Markus Thommes
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 24, 2020
Impact of structural relaxation on mechanical properties of amorphous polymersKarsten Flügel, Robert Hennig, Markus Thommes
Molecular Pharmaceutics|August 8, 2015
Branched Polymer-Drug Conjugates for Multivalent Blockade of Angiotensin II ReceptorsRobert Hennig, Anika Veser, Susanne Kirchhof, et al.
Journal of Drug Targeting|May 8, 2015
Multivalent targeting of AT1 receptors with angiotensin II-functionalized nanoparticlesRobert Hennig, Klaus Pollinger, Joerg Tessmar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 17, 2014
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylationRobert Hennig, Klaus Pollinger, Anika Veser, et al.
Journal of Drug Targeting|March 15, 2016
Cyclic RGD peptides target human trabecular meshwork cells while ameliorating connective tissue growth factor-induced fibrosisRobert Hennig, Sabrina Kuespert, Alexandra Haunberger, et al.
Soft Robotics|January 8, 2024
Educational Soft Underwater Robot with an Electromagnetic ActuationRobert Hennig, Alex Beaudette, Holly M Golecki, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 31, 2020
Impact of incorporated drugs on material properties of amorphous solid dispersionsKarsten Flügel, Katharina Schmidt, Lena Mareczek, et al.
Pharmaceutics|March 27, 2025
Modeling Shear-Thinning Flow in Twin-Screw Extrusion ProcessesVincent Kimmel, Lorena Gräfe, Luca Grieser, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2015
Nanoparticles for the treatment of ocular neovascularizationsRobert Hennig, Achim Goepferich
Journal of Pharmaceutical Sciences|August 27, 2019
Determination of the Structural Relaxation Enthalpy Using a Mathematical ApproachKarsten Flügel, Robert Hennig, Markus Thommes
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 24, 2020
Impact of structural relaxation on mechanical properties of amorphous polymersKarsten Flügel, Robert Hennig, Markus Thommes
Molecular Pharmaceutics|August 8, 2015
Branched Polymer-Drug Conjugates for Multivalent Blockade of Angiotensin II ReceptorsRobert Hennig, Anika Veser, Susanne Kirchhof, et al.
Journal of Drug Targeting|May 8, 2015
Multivalent targeting of AT1 receptors with angiotensin II-functionalized nanoparticlesRobert Hennig, Klaus Pollinger, Joerg Tessmar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 17, 2014
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylationRobert Hennig, Klaus Pollinger, Anika Veser, et al.
Journal of Drug Targeting|March 15, 2016
Cyclic RGD peptides target human trabecular meshwork cells while ameliorating connective tissue growth factor-induced fibrosisRobert Hennig, Sabrina Kuespert, Alexandra Haunberger, et al.
Soft Robotics|January 8, 2024
Educational Soft Underwater Robot with an Electromagnetic ActuationRobert Hennig, Alex Beaudette, Holly M Golecki, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 31, 2020
Impact of incorporated drugs on material properties of amorphous solid dispersionsKarsten Flügel, Katharina Schmidt, Lena Mareczek, et al.
Pharmaceutics|March 27, 2025
Modeling Shear-Thinning Flow in Twin-Screw Extrusion ProcessesVincent Kimmel, Lorena Gräfe, Luca Grieser, et al.
Pageof 2